• SENSEX 80,924.43
    33.41 (+0.04%)
  • BANKNIFTY 56,084.90
    -444.00 (--0.79%)
  • Larsen & Toubro
    3,451.45 3,963.00(%)
  • Vimta Labs
    709.00 677.70(%)
  • Waaree Energies
    3,291.95 3,740.75(%)
  • Paradeep Phosph.
    234.05 205.60(%)
  • Jayaswal Neco
    49.42 55.34(%)
  • Kajaria Ceramics
    1,181.60 1,578.25(%)
  • Mazagon Dock
    2,644.90 1,917.95(%)
  • Bharti Airtel
    1,914.90 2,045.50(%)
  • Bharat Electron
    378.25 240.15(%)
  • Go Digit General
    374.60 407.55(%)
  • Tata Chemicals
    999.00 1,244.70(%)
  • Suzlon Energy
    61.78 86.04(%)
  • TCS
    3,044.45 3,060.25(%)
  • Bajaj Finance
    886.00 978.59(%)
  • Indian Energy Ex
    132.00 131.50(%)
  • HDFC Bank
    2,019.40 2,035.00(%)
  • Adani Green
    994.45 758.00(%)
  • Infosys
    1,496.60 1,307.10(%)
  • Hind.Aeronautics
    4,411.90 3,045.95(%)
  • Coforge
    1,692.90 1,120.01(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Alpa Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 27710.0
  • ISIN : INE385I01010
101.12 -1 (-0.99%)
  • As on 29 Jul 2025 (EOD)

  • Today’s Low

    100.51

  • Today’s High

    102.67

  • Open

    102.49

  • Perv Close

    102.13

  • 52W Low

    90.11

  • 52W High

    144.50

Key Indicators

  • P/E(TTM)

    10.80

  • Mar.Cap (₹Cr.)

    212.76

  • Div & Yield %

    0.00

  • Book Value(₹)

    86.40

  • Debt-Equity Ratio

    -0.99

  • AGM Date

    28-Jul-2025

  • EPS

    9.35

  • P/E Ratio

    10.80

Financials Ratios

  • Debt-Equity Ratio

    0.03

  • Mar.Cap (₹Cr.)

    212.76

  • RONW (%)

    11.71

  • ROCE (%)

    14.32

Score Board

  • Equity (₹ in Cr.)

    21.04

  • BV (₹)

    86.40

  • Sales( ₹ in Cr.)

    111.64

  • NP (in Cr.)

    19.68

  • NP Var(%)

    14.0

  • Div%

    0.0

  • CPS (₹)

    10.40

  • EPS (₹)

    9.40

  • Traded Value (₹ in Lakhs)

    212.51

  • 52 Week High

    144.50

  • 52 Week Low

    90.11

  • Price BSE

    101.0

  • Price NSE

    101.00

  • Market Capital( in Cr.)

    212.51

  • P/C Ratio

    9.70

  • P/E Ratio

    10.80

  • Price Vs.BV

    9.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 108.74 92.96 112.27 97.55 85.97 77.99
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 108.74 92.96 112.27 97.55 85.97 77.99
Other Income 14.87 9.41 10.79 4.41 2.97 5.07
Stock Adjustments 0.64 -1.27 -0.53 1.15 0.42 -1.53
Total Income 124.25 101.10 122.53 103.11 89.36 81.53
EXPENDITURE :            
Raw Materials 68.68 53.67 69.24 60.62 51.42 47.31
Power and Fuel Cost 3.02 3.04 2.64 2.43 2.21 2.01
Employee Cost 13.26 12.17 11.93 11.75 11.82 12.04
Other Manufacturing Expenses 3.62 3.69 3.69 2.86 2.07 2.25
Selling and Administration Expenses 8.64 7.42 8.29 7.56 8.79 8.19
Miscellaneous Expenses 4.02 3.62 5.25 5.79 6.64 3.44
Employee Benefit Expenses 13.26 12.17 11.93 11.75 11.82 12.04
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 101.24 83.60 101.04 91.00 82.94 75.25
Operating Profit 23.02 17.48 21.48 12.12 6.42 6.29
Interest 0.39 0.22 0.24 0.10 0.20 0.57
Gross Profit 22.63 17.26 21.24 12.02 6.22 5.72
Depreciation 1.95 1.33 1.66 1.23 1.14 1.10
Profit Before Tax 20.68 15.93 19.58 10.79 5.08 4.62
Current Tax 3.78 3.60 3.10 2.39 1.75 1.08
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.11 -0.29 2.35 1.14 -0.75 0.59
Reported Net Profit 16.78 12.62 14.13 7.26 4.08 2.95
Extraordinary Items -0.41 -0.01 6.38 2.10 -1.31 0.28
Adjusted Net Profit 17.19 12.63 7.75 5.16 5.39 2.67
Adjustment below Net Profit 0.08 0.85 0.00 0.03 0.03 -0.07
P & L Balance brought forward 69.11 55.64 41.51 34.23 30.13 27.24
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 85.97 69.11 55.64 41.52 34.23 30.13
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 7.97 6.00 6.71 3.45 1.94 1.40
Earnings Per Share(Adj)-Unit Curr 7.97 6.00 6.71 3.45 1.94 1.40
Book Value 76.98 68.97 62.56 55.85 52.39 50.44
Book Value(Adj)-Unit Curr 76.98 68.97 62.56 55.85 52.39 50.44

Shareholding Pattern

  • Promoter Group

    57.29%

  • Public Share Holding

    42.71%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 12,055,010 57.29 12,055,010 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 12,055,010 57.29 12,055,010 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 76,533 0.36 76,533 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 76,533 0.36 76,533 2
2] Non Institution
Bodies Corporate 143,945 0.68 143,945 41
Clearing Members 4,442 0.02 4,442 6
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 645,699 3.07 645,699 393
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 271,219 1.29 271,219 328
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,267,216 6.02 1,267,216 25
Individuals holding nominal share capital up to Rs. 1 lakh 6,576,536 31.26 6,571,336 18,046
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 8,909,057 42.34 8,903,857 18,839
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 21,040,600 100.00 21,035,400 18,851

Company Background

Alpa Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Alpa Laboratories Ltd
  • BSE Code : 27710.0
  • ISIN : INE385I01010

  • Incorporation Year

    1988

  • Registered Office

    33/2 Pigdamber
    A B Road Rau, Indore,
    Madhya Pradesh-453446

  • Telephone

    91-731-4294567

  • FAX

    91-731-4294444

  • Chairman

    Mahendra Singh Chawla

  • Managing Director

    Paresh Chawla

  • Company Secretary

    Srashti Chopra

  • Auditor

    Padliya & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Alpa Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Alpa Laboratorie 101.00 123.61 108.74 10.80 13.38
Abbott India 32,886.45 6,684.73 6,409.15 49.41 44.95
Astrazeneca Phar 8,945.00 1,756.92 1,716.29 193.20 32.94
P & G Health Ltd 5,846.65 1,166.89 1,151.26 38.64 39.76
Glaxosmi. Pharma 3,088.80 3,866.05 3,723.49 56.94 58.72
Cipla 1,570.95 20,029.57 19,044.85 23.48 21.40
Amrutanjan Healt 661.15 437.58 421.23 37.61 20.84
Fermenta Biotec. 377.00 442.21 430.53 16.41 17.61
Guj. Themis Bio. 367.70 174.19 169.82 82.08 44.82
Bliss GVS Pharma 155.10 703.42 667.20 23.72 9.16
Ambalal Sarabhai 32.27 19.33 4.04 29.88 2.10